To address the critical deficit of verified purity in modern therapeutic research, we established a meticulous sequence synthesis framework. Our clinical supply chain prioritizes uncompromising batch fidelity over high-speed yields, ensuring researchers receive perfectly structured sequences that produce reliable, highly reproducible outcomes.
Every batch undergoes exhaustive multi-phase validation. We utilize High-Performance Liquid Chromatography (HPLC) to establish raw purity profiles, coupled with high-resolution Mass Spectrometry (MS) to confirm precise molecular mass and absolute structural sequence configuration. Additionally, our intensive endotoxin screening protocols assure bio-safety and zero-interference baselines.